Similar articles for PMID: 27354653

Year	Number of Results
1994	1
1995	2
1996	2
1997	2
1998	1
1999	1
2000	1
2002	3
2003	2
2004	3
2005	2
2006	4
2007	4
2008	7
2009	2
2010	7
2011	4
2012	5
2013	7
2014	10
2015	5
2016	5
2017	6
2018	1
2020	4
2021	0

1

Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis.

Inui T, Katsuura G, Kubo K, Kuchiike D, Chenery L, Uto Y, Nishikata T, Mette M. Inui T, et al. Anticancer Res. 2016 Jul;36(7):3771-4. Anticancer Res. 2016. PMID: 27354653

2

Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.

Yamamoto N, Suyama H, Nakazato H, Yamamoto N, Koga Y. Yamamoto N, et al. Cancer Immunol Immunother. 2008 Jul;57(7):1007-16. doi: 10.1007/s00262-007-0431-z. Cancer Immunol Immunother. 2008. PMID: 18058096 Retracted.

3

Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.

Yamamoto N, Naraparaju VR. Yamamoto N, et al. Cancer Res. 1997 Jun 1;57(11):2187-92. Cancer Res. 1997. PMID: 9187119 Free article. Clinical Trial.

4

Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports.

Inui T, Kubo K, Kuchiike D, Uto Y, Nishikata T, Sakamoto N, Mette M. Inui T, et al. Anticancer Res. 2015 Aug;35(8):4545-9. Anticancer Res. 2015. PMID: 26168499

5

Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.

Koga Y, Naraparaju VR, Yamamoto N. Koga Y, et al. Proc Soc Exp Biol Med. 1999 Jan;220(1):20-6. doi: 10.1046/j.1525-1373.1999.d01-3.x. Proc Soc Exp Biol Med. 1999. PMID: 9893164

6

Case report: A breast cancer patient treated with GcMAF, sonodynamic therapy and hormone therapy.

Inui T, Makita K, Miura H, Matsuda A, Kuchiike D, Kubo K, Mette M, Uto Y, Nishikata T, Hori H, Sakamoto N. Inui T, et al. Anticancer Res. 2014 Aug;34(8):4589-93. Anticancer Res. 2014. PMID: 25075104

7

Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).

Yamamoto N, Suyama H, Yamamoto N, Ushijima N. Yamamoto N, et al. Int J Cancer. 2008 Jan 15;122(2):461-7. doi: 10.1002/ijc.23107. Int J Cancer. 2008. PMID: 17935130 Free article. Retracted.

8

Case Report: A Non-small Cell Lung Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Tumor Treating Fields.

Inui T, Amitani H, Kubo K, Kuchiike D, Uto Y, Nishikata T, Mette M. Inui T, et al. Anticancer Res. 2016 Jul;36(7):3767-70. Anticancer Res. 2016. PMID: 27354652

9

Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).

Yamamoto N, Ushijima N, Koga Y. Yamamoto N, et al. J Med Virol. 2009 Jan;81(1):16-26. doi: 10.1002/jmv.21376. J Med Virol. 2009. PMID: 19031451 Retracted.

10

Gc protein-derived macrophage activating factor (GcMAF): isoelectric focusing pattern and tumoricidal activity.

Mohamad SB, Nagasawa H, Sasaki H, Uto Y, Nakagawa Y, Kawashima K, Hori H. Mohamad SB, et al. Anticancer Res. 2003 Nov-Dec;23(6a):4451-7. Anticancer Res. 2003. PMID: 14666733

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed